# Safety and Efficacy of Modern Stents in Patients with Metabolic Syndrome
## 3 Results
### Angiographic Characteristics  
The baseline angiographic and lesion characteristics of the study population are summarized in Table 5. The angiographic profile revealed higher preponderance of multivessel disease in MS patients (58.82%), comparing to single vessel disease observed in 41.18% of enrolled patients. However, the presence of involvement of more than one vessel was 62.91% of patients who underwent 2 nd generation DES stenting versus 47.16 of patients with other type of stents implanted. As regards ACS-related artery location (i.e., culprit vessel), left main coronary artery involvement was found more common in 2 nd generation  
\begin{table}
\begin{tabular}{c c c c} \hline \hline
**MS Components** & **2 nd Generation DES** & **Other Stents** & \\  & **(_n_ = 151_)** & **(_n_ = 53_)** & _p_-Value** \\ \hline Triads, \(n\) (\%) & & & \\ BMI + HDLc + DM & 1 (0.66) & 0 & 0.55 \\ BMI + HTg + HDLc & 11 (7.28) & 2 (3.77) & 0.37 \\ BMI + HTN + DM & 3 (1.98) & 7 (13.20) & 0.00 \\ BMI + HTN + HDLc & 33 (21.85) & 12 (22.64) & 0.91 \\ BMI + HTN + HTg & 11 (7.28) & 4 (7.54) & 0.95 \\ \hline Tetrads, \(n\) (\%) & & & \\ BMI + HTg + HDLc + DM & 4 (2.64) & 0 & 0.23 \\ BMI + HTN + HDLc + DM & 16 (10.59) & 8 (15.09) & 0.38 \\ BMI + HTN + HTg + DM & 7 (4.63) & 0 & 0.11 \\ BMI + HTN + HTg + HDLc & 39 (25.82) & 10 (18.86) & 0.31 \\ \hline With all the components, \(n\) (\%) & & & \\ BMI + HTN + HTg + HDLc + DM & 26 (17.21) & 10 (18.86) & 0.79 \\ \hline \hline \end{tabular} Abbreviations: Des, drug eluting stent; MS, metabolic syndrome; BMI, body mass index over 30 kg/m\({}^{2}\); DM, diabetes mellitus; HDLc, low high-density lipoprotein cholesterol; HTg, hypertriglyceridemia; HTN, hypertension.  
\end{table}
Table 2: Most frequent combinations of the metabolic syndrome components.  
\begin{table}
\begin{tabular}{c c c c} \hline \hline
**Variable** & **2 nd Generation DES** & **Other Stents** & _p_**-Value** \\  & **(_n_ = 151_)** & **(_n_ = 53_)** & _p_-Value** \\ \hline Initial diagnosis & & & \\ STEMI, \(n\) (\%) & 73 (48.34) & 26 (49.05) & 0.93 \\ NSTEMI, \(n\) (\%) & 46 (30.46) & 11 (20.75) & 0.18 \\ UA, \(n\) (\%) & 32 (21.19) & 16 (30.18) & 0.19 \\ Presentation & & & \\ Onset to balloon time (h), mean \(\pm\) SD & 47.39 \(\pm\) 57.74 & 49.63 \(\pm\) 59.07 & 0.81 \\ Door to balloon time (h), mean \(\pm\) SD & 33.09 \(\pm\) 49.84 & 31.67 \(\pm\) 47.32 & 0.86 \\ \(\leq\)120 min from door to balloon, \(n\) (\%) & 59 (39.07) & 21 (39.62) & 0.94 \\
120–180 min from door to balloon, \(n\) (\%) & 7 (4.63) & 1 (1.88) & 0.38 \\ Killip class I, \(n\) (\%) & 95 (62.91) & 30 (56.60) & 0.94 \\ Killip class II, \(n\) (\%) & 46 (30.46) & 21 (39.62) & 0.22 \\ Acute pulmonary edema, (\%) & 9 (5.96) & 2 (3.77) & 0.54 \\ Cardiogenic shock, \(n\) (\%) & 1 (0.66) & 0 & 0.55 \\ Cardiopulmonary arrest on arrival, \(n\) (\%) & 5 (3.31) & 2 (3.77) & 0.87 \\ Ejection fraction, (\%),mean \(\pm\) SD & 50.68 \(\pm\) 10.30 & 51 \(\pm\) 10.03 & 0.84 \\ EF \textgreater{} 50\%, \(n\) (\%) & 73 (48.34) & 27 (50.94) & 0.75 \\ EF = 40-50\%, \(n\) (\%) & 58 (38.41) & 21 (39.62) & 0.88 \\ EF \textless{} 40\%, \(n\) (\%) & 20 (13.24) & 5 (9.43) & 0.47 \\ Diastolic dysfunction, \(n\) (\%) & 61 (40.39) & 24 (45.28) & 0.54 \\ Wall motion abnormality, \(n\) (\%) & 83 (54.96) & 29 (54.71) & 0.98 \\ \hline \hline \end{tabular}
\end{table}
Table 3: Initial diagnosis and presentation.  
DES group, meanwhile other stents were more frequently inserted into the right coronary artery. More lesion and stents characteristics are described in Table 5.